ISDA

Deposition Date 2017-01-24

Release Date 2018-03-14

Last Version Date 2024-05-08

Entry Detail

PDB ID:

5MXR

Keywords:

HYDROLASE

Title:

Crystal Structure of the Acquired VIM-2 Metallo-beta-Lactamase in Complex with ANT-330 Inhibitor

Biological Source:

Source Organism:

Pseudomonas aeruginosa (Taxon ID: 287)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.75 Å

R-Value Free:

0.24

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

I 2 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Beta-lactamase VIM-2
Gene (Uniprot):blaVIM-2
Chain IDs:A
Chain Length:232
Number of Molecules:1
Biological Source:Pseudomonas aeruginosa

UniProt ID:Q9K2N0 Pfam ID:PF00753 EC:3.5.2.6

Ligand Molecules

ACT

JTY

Primary Citation

SAR Studies Leading to the Identification of a Novel Series of Metallo-beta-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.

Leiris, S, Coelho, A, Castandet, J, Bayet, M, Lozano, C, Bougnon, J, Bousquet, J, Everett, M, Lemonnier, M, Sprynski, N, Zalacain, M, Pallin, T.D, Cramp, M.C, Jennings, N, Raphy, G, Jones, M.W, Pattipati, R, Shankar, B, Sivasubrahmanyam, R, Soodhagani, A.K, Juventhala, R.R, Pottabathini, N, Pothukanuri, S, Benvenuti, M, Pozzi, C, Mangani, S, De Luca, F, Cerboni, G, Docquier, J.D, Davies, D.T.Show

Acs Infect Dis. 5 131 140 (2019)

PMID: 30427656 DOI: 10.1021/acsinfecdis.8b00246

Abstact

The clinical effectiveness of carbapenem antibiotics such as meropenem is becoming increasingly compromised by the spread of both metallo-β-lactamase (MBL) and serine-β-lactamase (SBL) enzymes on mobile genetic elements, stimulating research to find new β-lactamase inhibitors to be used in conjunction with carbapenems and other β-lactam antibiotics. Herein, we describe our initial exploration of a novel chemical series of metallo-β-lactamase inhibitors, from concept to efficacy, in a survival model using an advanced tool compound (ANT431) in conjunction with meropenem.

Legend

Protein

Chemical

Disease

Primary Citation of related structures